Found 86 matching trials
A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma PHASE1 This study is a single-center, open Phase I study, to observe the effective...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma N/A This is a retrospective observational study of the therapeutic mechanism an...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Selinexor, Cyclophosphamide and Prednisone in Myeloma PHASE2 The trial is designed as a randomised, controlled, open, parallel group, mu...
Show More Location
Birmingham Heartlands Hospital
Learn More & Join Trial
Selinexor Combined With Induction Chemotherapy for Children With NUP98-positive AML PHASE2 This is a prospective, single-arm, open-label clinical study to evaluate th...
Show More Status
Active Not Recruiting
Location
Children's Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Selinexor (KPT-330) and Liposomal Doxorubicin For Relapsed and Refractory Multiple Myeloma PHASE1 The main purpose of this study is to determine the recommended doses of sel...
Show More Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma PHASE2 Phase 2, single-arm, open, non-randomized, multicenter study of the SINE™ c...
Show More Status
Active Not Recruiting
Location
Hospital Germans Trials i Pujol
Learn More & Join Trial
Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia PHASE3 This clinical trial studies the efficacy and safety of selinexor combined w...
Show More Learn More & Join Trial
Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial PHASE1 This phase I/II trial identifies the best dose and side effects of selinexo...
Show More Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Learn More & Join Trial
Second-line Immunotherapy for ES-SCLC NA At present, the first-line standard treatment for patients with extensive-s...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma PHASE2 Primary central nervous system diffuse large B-cell lymphoma (PCNSL-DLBCL) ...
Show More Location
Beijing Tongren Hospital, Capital Medical University
Learn More & Join Trial